Stephen Kent to Middle Aged
This is a "connection" page, showing publications Stephen Kent has written about Middle Aged.
Connection Strength
0.407
-
Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccines. JCI Insight. 2025 Jan 09; 10(4).
Score: 0.056
-
Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans. ACS Nano. 2024 10 01; 18(39):27077-27089.
Score: 0.055
-
Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults. Vaccine. 2017 11 07; 35(47):6451-6458.
Score: 0.034
-
Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment Interruption. J Virol. 2017 08 01; 91(15).
Score: 0.033
-
Antibody Responses with Fc-Mediated Functions after Vaccination of HIV-Infected Subjects with Trivalent Influenza Vaccine. J Virol. 2016 06 15; 90(12):5724-5734.
Score: 0.031
-
Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells. J Virol. 2016 02 15; 90(4):2021-30.
Score: 0.030
-
Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial. J Infect Dis. 2025 Dec 20; 232(6):1319-1329.
Score: 0.015
-
HLA-B*15:01-positive severe COVID-19 patients lack CD8+ T cell pools with highly expanded public clonotypes. Proc Natl Acad Sci U S A. 2025 Sep 09; 122(36):e2503145122.
Score: 0.015
-
Genetic markers of enhanced functional antibody responses to COVID-19 vaccination. Vaccine. 2025 Aug 13; 61:127379.
Score: 0.015
-
SARS-CoV-2-specific CD8+ T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 years. Proc Natl Acad Sci U S A. 2024 Sep 24; 121(39):e2411428121.
Score: 0.014
-
Immune imprinting in early life shapes cross-reactivity to influenza B virus haemagglutinin. Nat Microbiol. 2024 Aug; 9(8):2073-2083.
Score: 0.014
-
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster. EBioMedicine. 2023 Dec; 98:104878.
Score: 0.013
-
Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain. Cell Rep. 2021 10 12; 37(2):109822.
Score: 0.011
-
Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients. Nat Commun. 2021 05 11; 12(1):2691.
Score: 0.011
-
CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity. Immunity. 2021 05 11; 54(5):1066-1082.e5.
Score: 0.011
-
Systems serology detects functionally distinct coronavirus antibody features in children and elderly. Nat Commun. 2021 04 01; 12(1):2037.
Score: 0.011
-
Integrated immune dynamics define correlates of COVID-19 severity and antibody responses. Cell Rep Med. 2021 03 16; 2(3):100208.
Score: 0.011
-
Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype. Proc Natl Acad Sci U S A. 2020 09 29; 117(39):24384-24391.
Score: 0.010
-
Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope Vaccine. Hum Gene Ther. 2018 09; 29(9):1011-1028.
Score: 0.009
-
Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease. Front Immunol. 2018; 9:1076.
Score: 0.009